Buscar
Mostrando ítems 1-10 de 143
Interchangeability among therapeutic equivalents of lamotrigine: evaluation of quality of life
(UNIV SAO PAULO, CONJUNTO QUIMICASSAO PAULO, 2012)
Epilepsy is the most common serious neurological disorder worldwide. Approximately 70% of patients with epilepsy have their seizures controlled by clinical and pharmacological treatment. This research evaluated the possible ...
Levotiroxina e o problema da permutabilidade de drogas de estreito intervalo terapêuticoLevothyroxine and the problem of interchangeability of drugs with narrow therapeutic index
(Sociedade Brasileira de Endocrinologia e Metabologia, 2011)
Interchangeability of biological drugs: Considerations about the approval of biogeneric formulations in Chile Intercambiabilidad de medicamentos de origen biológico (biofármacos): Consideraciones acerca de la aprobación de formulaciones biosimilares (biog
(2006)
Once drug patents expire, the health authorities can approve the registry of similar products. They must request to the manufacturer, the bibliographic background of the original product and the analytical results that ...
New monoclonal antibody biosimilars approved in 2015 in Latin America: Position statement of the Latin American Forum on Biosimilars in biosimilarity, interchangeability and extrapolation of indications
(Pro Pharma Communications International, 2016-06)
Introduction: The Latin American Forum on Biosimilars (FLAB) is an annual meeting that brings together various stakeholders, including key opinion leaders, the pharmaceutical industry, academics, patients, lawyers and other ...
Interchangeability among therapeutics equivalents of lamotrigine in the treatment of refractory epilepsy patients: risks and benefits
(REVISTA DE NEUROLOGIA, 2010)
Introduction. Epilepsy is a condition characterized by signs and symptoms of neurological disorder. Lamotrigine has been widely used, mainly due to their greater tolerability and lower rate of drug interactions with other ...
Interchangeability among therapeutic equivalents of lamotrigine: evaluation of quality of life
(Universidade de São Paulo, Faculdade de Ciências Farmacêuticas, 2012)
Epilepsy is the most common serious neurological disorder worldwide. Approximately 70% of patients with epilepsy have their seizures controlled by clinical and pharmacological treatment. This research evaluated the possible ...
Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
(Springer, 2019)
The use of biosimilar drugs for multiple sclerosis (MS) has become widespread in Latin America, with the goal of reducing costs of treatments, promoting the sustainability of healthcare systems, and improving patient ...